Call for lead investigators for the DETERMINE trial

DETERMINE (Determining Extended Therapeutic indications for Existing drugs in Rare Molecularly defined Indications using a National Evaluation platform trial) is a multi-drug, precision medicine trial for adults, teenagers and children with rare cancers.

The DETERMINE trial is calling for motivated clinicians who may be interested and/or have experience with rare tumour types and would like to become a lead investigator for one of the treatment arms within the DETERMINE trial.

This call has now ended.

Find out more about DETERMINE